Shareholder Conference Call Invitation For March 22, 2023
Link to the PDF: CLICK HERE
You are invited to a shareholder conference call for Predictive Oncology (NASDAQ: POAI) on Wednesday, March 22, 2023 at 12:00 PM ET.
We look forward to sharing about our latest developments and exciting updates, including the new strategic partnership with Cvergenx that has the potential to revolutionize the field of radiation oncology with the first-ever genomics based artificial intelligence approach to personalized radiotherapy and drug discovery. Participants will also hear about the launch of our ACE program to partner with academic and research institutions to advance their drug discovery initiatives. On the call will be Raymond F. Vennare, Chief Executive Officer and Chairman of the Board, Bob Myers, Chief Financial Officer, and Dr. Pamela Bush, Chief Business Officer. After the overview, we’ll open up the discussion for Q&As.
The link to register for the webcast will be available at:
Participant Teleconference Registration Link: